Testostérone plasmatique, obésité, syndrome métabolique et diabète

Simon, 1997, Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study, J Clin Endocrinol Metab, 82, 682 Dhindsa, 2004, Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes, J Clin Endocrinol Metab, 89, 5462, 10.1210/jc.2004-0804 Pitteloud, 2005, Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men, J Clin Endocrinol Metab, 90, 2636, 10.1210/jc.2004-2190 Kapoor, 2006, Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes, Eur J Endocrinol, 154, 899, 10.1530/eje.1.02166 Mingrone, 2002, Sex hormone-binding globulin levels and cardiovascular risk factors in morbidly obese subjects before and after weight reduction induced by diet or malabsorptive surgery, Atherosclerosis, 161, 455, 10.1016/S0021-9150(01)00667-0 Dhindsa, 2010, Testosterone concentrations in diabetic and nondiabetic obese men, Diabetes Care, 33, 1186, 10.2337/dc09-1649 Barrett-Connor, 1992, Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus, Ann Intern Med, 117, 807, 10.7326/0003-4819-117-10-807 Andersson, 1994, Testosterone concentrations in women and men with NIDDM, Diabetes Care, 17, 405, 10.2337/diacare.17.5.405 Oh, 2002, Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study, Diabetes Care, 25, 55, 10.2337/diacare.25.1.55 Haffner, 1996, Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial, Am J Epidemiol, 143, 889, 10.1093/oxfordjournals.aje.a008832 Ding, 2006, Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis, JAMA, 295, 1288, 10.1001/jama.295.11.1288 Vermeulen, 1996, Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males, J Clin Endocrinol Metab, 81, 1821 Katznelson, 1996, Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism, J Clin Endocrinol Metab, 81, 4358 Bhasin, 1997, Testosterone replacement increases fat-free mass and muscle size in hypogonadal men, J Clin Endocrinol Metab, 82, 407 Snyder, 1999, Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age, J Clin Endocrinol Metab, 84, 2647 Bhasin, 1998, Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels, J Clin Endocrinol Metab, 83, 3155 Pasquali, 1995, Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men, J Clin Endocrinol Metab, 80, 654 Reis, 2010, Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial, Int J Androl, 3, 736, 10.1111/j.1365-2605.2009.01017.x Grossmann, 2008, Low testosterone levels are common and associated with insulin resistance in men with diabetes, J Clin Endocrinol Metab, 93, 1834, 10.1210/jc.2007-2177 Tripathy, 2003, Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect?, Metab Syndr Relat Disord, 1, 75, 10.1089/154041903321648270 Russell, 2001, The in vitro role of tumour necrosis factor-alpha and interleukin-6 in the hypothalamic-pituitary gonadal axis, J Neuroendocrinol, 13, 296, 10.1046/j.1365-2826.2001.00632.x Watanobe, 2003, Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats, Endocrinology, 144, 4868, 10.1210/en.2003-0644 Brüning, 2000, Role of brain insulin receptor in control of body weight and reproduction, Science, 289, 2122, 10.1126/science.289.5487.2122 Loves, 2008, Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism, Eur J Endocrinol, 158, 741, 10.1530/EJE-07-0663 Lima, 2000, Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat, Int J Obes Relat Metab Disord, 24, 1433, 10.1038/sj.ijo.0801406 Pitteloud, 2005, Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men, Diabetes Care, 28, 1636, 10.2337/diacare.28.7.1636 Isidori, 1999, Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels, J Clin Endocrinol Metab, 84, 3673 Jones, 2007, Hypogonadism in men with type 2 diabetes, Pract Diab Int, 24, 269, 10.1002/pdi.1117 Corona, 2011, Testosterone and metabolic syndrome: a meta-analysis study, J Sex Med, 8, 272, 10.1111/j.1743-6109.2010.01991.x Brand, 2011, Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies, Int J Epidemiol, 40, 189, 10.1093/ije/dyq158 Laaksonen, 2004, Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men, Diabetes Care, 27, 1036, 10.2337/diacare.27.5.1036 Kupelian, 2006, Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men, J Clin Endocrinol Metab, 91, 843, 10.1210/jc.2005-1326 Sonmez, 2011, Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism, Eur J Endocrinol, 164, 759, 10.1530/EJE-10-0951 Haring, 2009, Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania, Diabetes, 58, 2027, 10.2337/db09-0031 Rodriguez, 2007, Aging, androgens, and the metabolic syndrome in a longitudinal study of aging, J Clin Endocrinol Metab, 92, 3568, 10.1210/jc.2006-2764 Bojesen, 2006, Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses, J Clin Endocrinol Meta., 91, 1254, 10.1210/jc.2005-0697 Yialamas, 2007, Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism, J Clin Endocrinol Metab, 92, 4254, 10.1210/jc.2007-0454 Boyanov, 2003, Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency, Aging Male, 6, 1, 10.1080/tam.6.1.1.7 Heufelder, 2009, Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone, J Androl, 30, 726, 10.2164/jandrol.108.007005 Haider, 2010, A safety study of administration of parenteral testosterone undecanoate to elderly men over minimally 24 months, Andrologia, 42, 349, 10.1111/j.1439-0272.2009.01016.x Kalinchenko, 2010, Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study, Clin Endocrinol, 73, 602, 10.1111/j.1365-2265.2010.03845.x Braga-Basaria, 2006, Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy, J Clin Oncol, 20, 3979, 10.1200/JCO.2006.05.9741 Basaria, 2006, Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy, Cancer, 106, 581, 10.1002/cncr.21642 Smith, 2001, The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer, J Clin Endocrinol Metab, 86, 4261, 10.1210/jcem.86.9.7851 Kaukua, 2003, Sex hormones and sexual function in obese men losing weight, Obes Res, 11, 689, 10.1038/oby.2003.98 Niskanen, 2004, Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome, Diabetes Obes Metab, 6, 208, 10.1111/j.1462-8902.2004.00335.x Chubb, 2008, Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study, Eur J Endocrinol, 158, 785, 10.1530/EJE-07-0893 Ding, 2009, Sex hormone-binding globulin and risk of type 2 diabetes in women and men, N Engl J Med, 361, 1152, 10.1056/NEJMoa0804381 Perry, 2010, Genetic evidence that raised sex hormone-binding globulin (SHBG) levels reduce the risk of type 2 diabetes, Hum Mol Genet, 19, 535, 10.1093/hmg/ddp522 Bonnet, 2013, Role of sex steroids, intra-hepatic fat and liver enzymes in the association between SHBG and metabolic features, Clin Endocrinol, 79, 517, 10.1111/cen.12089 Foresta, 2010, Evidence for osteocalcin production by adipose tissue and its role in human metabolism, J Clin Endocrinol Metab, 95, 3502, 10.1210/jc.2009-2557 Oury, 2011, Endocrine regulation of male fertility by the squeleton, Cell, 144, 796, 10.1016/j.cell.2011.02.004 Kanazawa, 2013, Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus, Osteoporos Int, 24, 1115, 10.1007/s00198-012-2017-7 Foresta, 2011, Androgens modulate osteocalcin release by human visceral adipose tissue, Clin Endocrinol, 75, 64, 10.1111/j.1365-2265.2011.03997.x Vermeulen, 1999, A critical evaluation of simple methods for the estimation of free testosterone in serum, J Clin Endocrinol Metab, 84, 3666, 10.1210/jcem.84.10.6079 Laaksonen, 2003, Sex hormones, inflammation and the metabolic syndrome: a population-based study, Eur J Endocrinol, 149, 601, 10.1530/eje.0.1490601 Tsai, 2004, Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat, Diabetes Care, 27, 861, 10.2337/diacare.27.4.861 Allan, 2010, Androgens and obesity, Curr Opin Endocrinol Diabetes Obes, 17, 224, 10.1097/MED.0b013e3283398ee2 Selvin, 2007, Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III), Diabetes Care, 30, 234, 10.2337/dc06-1579 Keating, 2006, Diabetes and cardiovascular disease during androgen-deprivation therapy for prostate cancer, J Clin Oncol, 24, 4448, 10.1200/JCO.2006.06.2497 Derweesh, 2007, Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer, BJU Int, 100, 1060 Haidar, 2007, Effects of androgen-deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes, Aging Male, 10, 189, 10.1080/13685530701653538 Smith, 2006, Insulin sensitivity during combined androgen blockade for prostate cancer, J Clin Endocrinol Metab, 91, 1305, 10.1210/jc.2005-2507 Mårin, 1992, The effects of testosterone treatment on body composition and metabolism in middle-aged obese men, Int J Obes Relat Metab Disord, 16, 991 Morimoto, 2005, Protective effect of testosterone on early apoptotic damage induced by streptozotocin in rat pancreas, J Endocrinol, 187, 217, 10.1677/joe.1.06357 Bhatia, 2006, Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes, Diabetes Care, 29, 2289, 10.2337/dc06-0637 Dandona, 2004, Inflammation: the link between insulin resistance, obesity and diabetes, Trends Immunol, 25, 4, 10.1016/j.it.2003.10.013 Gautier, 2013, Associations between visceral adipose tissue and sex steroid concentrations in men, Clin Endocrinol, 78, 373, 10.1111/j.1365-2265.2012.04401.x Tajar, 2010, Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study, J Clin Endocrinol Metab, 95, 1810, 10.1210/jc.2009-1796 van Dam, 2003, Steroids in adult men with type 1 diabetes: a tendency to hypogonadism, Diabetes Care, 26, 1812, 10.2337/diacare.26.6.1812 Chandel, 2008, Testosterone concentration in young patients with diabetes, Diabetes Care, 31, 2013, 10.2337/dc08-0851 Ali, 1993, Serum and urinary levels of pituitary – gonadal hormones in insulin-dependent and non-insulin-dependent diabetic males with and without neuropathy, Arch Androl, 30, 117, 10.3109/01485019308987744 Yeap, 2009, Lower testosterone levels predict incident stroke and transient ischemic attack in older men, J Clin Endocrinol Metab, 94, 2353, 10.1210/jc.2008-2416 Laughlin, 2008, Low serum testosterone and mortality in older men, J Clin Endocrinol Metab, 93, 68, 10.1210/jc.2007-1792 Grossmann, 2011, Low testosterone in men with type 2 diabetes: significance and treatment, J Clin Endocrinol Metab, 96, 2341, 10.1210/jc.2011-0118 Bhasin, 2011, Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the Framingham Heart Study, Diabetes Care, 34, 2464, 10.2337/dc11-0888 Yeap, 2009, Lower serum testosterone is independently associated with insulin resistance in nondiabetic older men: the Health In Men Study, Eur J Endocrinol, 161, 591, 10.1530/EJE-09-0348 Saad, 2012, Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review, Curr Diabetes Rev, 8, 131, 10.2174/157339912799424573 Jones, 2011, Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES 2 study), Diabetes Care, 34, 828, 10.2337/dc10-1233 Naharci, 2007, Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism, Endocr Pract, 13, 629, 10.4158/EP.13.6.629 Kapoor, 2007, The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes, Eur J Endocrinol, 156, 595, 10.1530/EJE-06-0737 Traish, 2007, Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction, Eur Urol, 52, 54, 10.1016/j.eururo.2007.02.034 Kalinchenko, 2003, Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone, Aging Male, 6, 94, 10.1080/713604767 Kalinchenko, 2009, Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases, Cardiovasc Diabetol, 8, 19, 10.1186/1475-2840-8-19 Akishita, 2007, Low testosterone level is an independent determinant of endothelial dysfunction in men, Hypertens Res, 30, 1029, 10.1291/hypres.30.1029 Saad, 2012, Restoring testosterone to normal levels in elderly men is efficacious in weight reduction. A follow-up study over five years